设为首页 加入收藏 中文版 English

The current position: Home>Cases

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged ... [more]
Cases

Systemic lupus erythematosus

XX, female, 46, diagnosed as systemic lupus erythematosus, secondary sjogren syndrome and autoimmune hepatopathy 6 years ago. The disease condition was not effectively controlled by traditional Chinese medicine and routine treatment. The symptoms of arthralgia, dry mouth, dry eye and cavity ulcer aggravated. The patient came for treatment of stem cell transplantation on April 24th of 2009.
 

Through the contrast result showed in table above, we can see that the liver function of the patient returned to normal, and the value of autoantibodies of TPOAb and TGAb gradually decreased, and the descending trend of various immunoglobulins, especially the pathogenic immunoglobulin of systemic lupus erythematosus lgG was within normal limits.Until now, the patient feel stamina increased, arthralgia relieved, and is satisfied with the treatment effectiveness and under continuous treatment.


Patient Bai, female, is 46 years old,systemic lupus erythematosus, xerosis syndrome, autoimmune liver harm.Patient Bai, female, is 46 years old, being suffered from joint pain along with canker sore for 6 years, feeling dry mouth and eyes 4 years, and two years of dizzy, headache, feeling increased fatigue 5 days. After checking, he was diagnosed with “systemic lupus erythematosus, xerosis syndrome, autoimmune liver harm.” She was sent to affiliated hospital to the China Medical University for systemic therapy. She was activated blood circulation by removing blood stasis, eliminating phlegm, and freeing channels by means of decoction of traditional Chinese medicine, together with other treatments, such as taking methylprednisolone, hydroxychloroquine, total glucosides of paeony, cooperating with enriching the calcium, stormach-protecting as well as liver-protecting combined treatments. The patient’s medical conditions showed a certain extent alleviated, and relative stability. Well, her medical condition kept on developing, various symptoms are even worsening after leaving hospital.
 

Accessory test shows:
anti-DNA antibody (+), complement C3 (0.70), C4 (0.12), immunoglobulin IgG (18.70), IgA (6.27), IgM4.43, erythrocyte sedimentation rate (24), liver function (alanine aminotransferase (58), aspartate aminotransferase (63), alkaline phosphatase (157), GGTP (118), Total Bilirubin (212).The above mentioned patient was treated with embryonic stem cell transplantation therapy for the first time in April 14th, 2009. And the patient felt improving the quality of her sleep and promoting appetite three days after the transfer of embryonic stem cell into her body. And the symptoms of her joint pain relieves significantly, reducing of frequency of her headache, feeling dizzy, fatigue within a week time after transplantation. But it seemed that her dry mouth and eyes did not relieve obviously. In May 13th, 2009, she was given with the second time of stem cell transplantation therapy, and this time the patient did feel the symptoms of her dry mouth and eyes are relieved accordingly. The patient’s condition, in generally, is good, vital signs shows stable, refreshing brain and clearly language speak, sound sleep, feeling appetite, excretory functions are normal.
 

Accessory test shows:
complement C3 (1.05), C4 (0.20), immunoglobulin IgG (16.56), IgA (5.07), IgM(2.79, erythrocyte sedimentation rate (7), liver function (alanine aminotransferase (27), aspartate aminotransferase (20), alkaline phosphatase (62), GGTP (47), Total Bilirubin (16.3).And now the patient is ready for the treatment of embryonic stem cell transplantation therapy for the third time.

上一篇:Tumor

下一篇:Anti-aging

版权所有© 吉林省中科生物工程有限公司 吉ICP备12000258号
客服
live chat